Natural course and treatment outcomes of arteriovenous shunts below the conus medullaris.
Abstract
[OBJECTIVE] Arteriovenous shunts below the conus medullaris (AVS-BC) have an unstudied natural history. The aim of this study was to elucidate the natural history of AVS-BC and to clarify the clinical onset, progression, and treatment outcomes for management strategy optimization.
[METHODS] A prospectively maintained database was retrospectively reviewed for consecutive symptomatic patients with AVS-BC between January 2000 and July 2023. Onset and deterioration patterns were categorized as acute or gradual and assessed using the modified Aminoff-Logue Scale (mALS) and modified Denis Pain and Numbness Scale (mDS). Time to deterioration before and after treatment was evaluated using Kaplan-Meier analysis, restricted cubic splines, and Cox and logistic regression modeling.
[RESULTS] The analysis included 132 patients (113 male, median age 54.5 years) with AVS-BC, with a median observational period of 9.00 months (IQR 5.25-12.00 months). Acute onset occurred in 18.2% of patients, with 16.7% experiencing acute deterioration. The overall pretreatment deterioration rate was 6.5% per month. Deterioration risk was highest shortly after the initial onset. Patients aged 50-70 years were less likely to experience deterioration (p = 0.02). Half the patients underwent embolization and 43.9% underwent microsurgery, with an anatomical cure achieved in most patients. The overall monthly deterioration rate after treatment was 0.5%. The mALS grade at admission was a significant risk factor for spinal motor deterioration (HR 0.60, 95% CI 0.45-0.79; p < 0.001). For sensory deterioration, risk factors included dural AVS-BC (HR 2.98, 95% CI 1.02-8.69; p = 0.046), a drainage diameter of 1.5-2.0 mm (HR 2.48, 95% CI 1.05-5.84; p = 0.038), and the admission mDS score (HR 1.66, 95% CI 1.24-2.21; p < 0.001). Deeper segments (L5-S1, HR 2.70, p = 0.024; S2-5, HR 13.00, p < 0.001) predicted embolization as the treatment modality.
[CONCLUSIONS] Rapid deterioration was observed among patients with AVS-BC, particularly after onset. While early treatments were beneficial for most patients, gradual deterioration after treatment warrants further research.
[METHODS] A prospectively maintained database was retrospectively reviewed for consecutive symptomatic patients with AVS-BC between January 2000 and July 2023. Onset and deterioration patterns were categorized as acute or gradual and assessed using the modified Aminoff-Logue Scale (mALS) and modified Denis Pain and Numbness Scale (mDS). Time to deterioration before and after treatment was evaluated using Kaplan-Meier analysis, restricted cubic splines, and Cox and logistic regression modeling.
[RESULTS] The analysis included 132 patients (113 male, median age 54.5 years) with AVS-BC, with a median observational period of 9.00 months (IQR 5.25-12.00 months). Acute onset occurred in 18.2% of patients, with 16.7% experiencing acute deterioration. The overall pretreatment deterioration rate was 6.5% per month. Deterioration risk was highest shortly after the initial onset. Patients aged 50-70 years were less likely to experience deterioration (p = 0.02). Half the patients underwent embolization and 43.9% underwent microsurgery, with an anatomical cure achieved in most patients. The overall monthly deterioration rate after treatment was 0.5%. The mALS grade at admission was a significant risk factor for spinal motor deterioration (HR 0.60, 95% CI 0.45-0.79; p < 0.001). For sensory deterioration, risk factors included dural AVS-BC (HR 2.98, 95% CI 1.02-8.69; p = 0.046), a drainage diameter of 1.5-2.0 mm (HR 2.48, 95% CI 1.05-5.84; p = 0.038), and the admission mDS score (HR 1.66, 95% CI 1.24-2.21; p < 0.001). Deeper segments (L5-S1, HR 2.70, p = 0.024; S2-5, HR 13.00, p < 0.001) predicted embolization as the treatment modality.
[CONCLUSIONS] Rapid deterioration was observed among patients with AVS-BC, particularly after onset. While early treatments were beneficial for most patients, gradual deterioration after treatment warrants further research.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | microsurgery
|
미세수술 | dict | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health.
- Application of the SCIA-Pure Skin Perforator Flap in Bilateral Upper Eyelid Reconstruction: A Case Report and Review of the Literature.
- Free flap reconstruction of a cast-related pressure ulcer in a pediatric patient with spinal muscular atrophy.
- Characterization of Trimmed Nerve Morphology Using High-Resolution Imaging: Comparison of Three Surgical Instruments.